Monitor the annual meeting outcome on November 17, 2026, particularly the equity plan amendment vote which could indicate shareholder sentiment on dilution. The CEO transition to Eric Honroth warrants attention for any strategic shifts in the coming quarters.
Price Chart
Executive Summary
AngioDynamics filed DEFA14A definitive additional proxy soliciting materials on October 8, 2026, in connection with its upcoming annual meeting. The filing is a routine management solicitation supporting the election of two Class II directors, ratification of the independent auditor, a say-on-pay vote, and an amendment to the 2020 Equity Incentive Plan to increase shares available for issuance. Concurrently, the company announced Eric Honroth as the new CEO and President effective November 2, 2026, with an employment agreement detailing a $735,000 base salary and 95% target bonus, signaling a leadership transition.
Key Financial Metrics
Key Facts
- Annual meeting scheduled for November 17, 2026, to be held virtually.
- Shareholders to vote on election of two Class II directors, ratification of auditor, say-on-pay, and amendment to 2020 Equity Incentive Plan.
- Board unanimously recommends FOR all proposals.
- Eric Honroth appointed CEO and President effective November 2, 2026, with base salary of $735,000 and 95% target bonus.
- Record date for voting is September 18, 2026.
Financial Impact
CEO compensation terms disclosed: $735,000 base salary and 95% target bonus; equity incentive plan amendment to increase share reserve (amount undisclosed).
Risk Factors
- Potential shareholder dissent on say-on-pay or equity plan amendment.
- Leadership transition risk as new CEO takes over.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-039093 |
| Document: 0001140361-26-039093-index-headers.html | 0001140361-26-039093 |
| Document: 0001140361-26-039093-index.html | 0001140361-26-039093 |
| Document: 0001140361-26-039093.txt | 0001140361-26-039093 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 19d ago | DEFA14A | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Oct 8, 2026 19d ago | DEF 14A | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Oct 8, 2026 19d ago | 8-K | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Oct 8, 2026 19d ago | 8-K | $11.23 $11.58 | ▲ +3.12% | ▲ +3.39% | $12.26 (+9.17%) |
Jul 14, 2026 15w ago | 8-K | $13.00 $13.71 | ▲ +5.46% | ▲ +6.76% | $12.26 (−5.69%) |
Apr 2, 2026 29w ago | 8-K | $10.31 $9.80 | ▼ −4.95% | ▼ −8.57% | $12.26 (+18.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers